Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA

Journal Title: NanoWorld Journal - Year 2015, Vol 1, Issue 2

Abstract

RNA interference and the therapeutic applications using small interfering RNA was discovered more than 10 years ago and currently is used in various applications including in therapeutic field. However the research in this field is still in its infancy. Many challenges like safe delivery of targeted siRNA to nucleus and cytosol of cancerous cells without compromising the activity of siRNA needs to be addressed. We have overcome this hurdle with the help of nanotechnology using PLGA hollow nanoparticles (PLGAHNPs) and suppressing the oncogene of MYC transcription factors by using anti myc-siRNAs in human cancer cell lines. siRNA was encapsulated in PLGAHNPs. These spherical PLGAHNPs of size 70 nm had high efficiency of gene release at pH 4.2 under in vitro conditions. Cell penetrating peptide (CPP)- Tat peptide (TAT) and peptide nucleic acidnucleolus localizing signal (PNA-NLS) was used for siRNA delivery without affecting the therapeutic activity of siRNA. The siRNA duplex was prepared using T7 polymerase and double stranded DNA through in vitro transcription. Incubation of the siRNA encapsulated PLGAHNPs functionalized with TAT and PNA-NLS (TAT-siRNA-PNA-PLGAHNPs-siRNA) with cancer cells resulted in reduced cell proliferation. A downregulation of gene expression by 90% was observed even with low concentration of siRNA. We found complete arrest of cell division which was mediated by downregulation of MYC expression.

Authors and Affiliations

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, D. Sakthi Kumar

Keywords

Related Articles

Introduction: Proceedings of the 2nd NanoWorld Conference in Boston (NWC-2017)

From April 3 to 5, 2017 in Newton (Boston, USA) we set the second NanoWorld Conference (NWC) around the theme “Useful Science and Technology for a Just World” to focus on progresses in Nanotechnology and Nanosciences cap...

NanoWorld Journal - Space Section, with Emphasis on SWaP

The high cost of escaping Earth’s gravity is the dominant factor that continues to limit large scale exploration and exploitation of space. With continuous technology advances, the cost of space launch is gradually decre...

Surface Modification Efficiency of Titanium-based Particles with an Alkyl Phosphate

This article reports the efficiency of surface modification of titanium particles based on an alkyl phosphate. Different techniques were used to evaluate the behavior of the samples after modification, in terms of better...

NAPPA-Based Vaccines for a New Proteogenomics Approach for Public Health

Vaccinology was developed for the first time in 1796 when Jenner empirically implemented a vaccine against smallpox using animal-to-human cowpox inoculation. Since then, it has become a very complex science due to the me...

Epitaxial Growth of Ruthenium Dioxides on Ru(0001) Surface

The epitaxial growth of the RuO2 clusters on Ru(0001) electrode formed by electrooxidation in HClO4 solution has been studied by ex-situ reflection high energy electron diffraction (RHEED), low energy electron diffractio...

Download PDF file
  • EP ID EP223085
  • DOI 10.17756/nwj.2015-005
  • Views 143
  • Downloads 0

How To Cite

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, D. Sakthi Kumar (2015). Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA. NanoWorld Journal, 1(2), 32-45. https://europub.co.uk/articles/-A-223085